Clin2
NCT07398001Possibly a fitNot yet recruiting

Stopping blood thinners after drug-coated balloon treatment

Percutaneous Coronary InterventionAntiplatelet TherapyDrug-coated Balloon

Part of Heart & circulation clinical trials.

This study looks at whether it is safe to stop taking antiplatelet medicines (blood thinners) more than a year after a procedure called drug-coated balloon treatment for blocked arteries. If you have been stable without heart attacks, strokes, or bleeding, you might be able to stop these medicines.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,042 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years or older.
  • You had a drug-coated balloon treatment at least 12 months ago.
  • You have not had a heart attack, stroke, or need for another procedure on the treated artery since then.
  • You have not had major bleeding since the procedure.
  • You are currently taking antiplatelet medicine (like aspirin or clopidogrel).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07764094Recruiting
Balloon treatment for blocked heart arteries

This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.

Chuzhou, Anhui
NCT07582835Recruiting· Phase 3
Long-term heart clot prevention after stent placement

This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.

Lugano, Ch/ti
NCT06742931Recruiting
Balloon vs stent for heart artery blockages in high bleeding risk patients

This trial compares a drug-coated balloon (medicated balloon) to a drug-eluting stent (medicated mesh tube) for treating new blockages in heart arteries. It is designed for patients with a high risk of bleeding who have completed a short course of anti-clotting medication and have been event-free for at least one year.

Ansan
NCT07587099Recruiting
Single vs. Dual Blood Thinners After Balloon Heart Treatment

This study compares whether patients who receive a special drug-coated balloon to open a blocked heart artery (without a stent) need to take one or two blood-thinning medications afterward. The goal is to find the safest and most effective approach for preventing future blockages.

Beijing, Beijing Municipality
NCT07815106Not yet recruiting· Phase 4
Shorter dual antiplatelet therapy after drug-coated balloon for coronary disease

This study tests whether a shorter period of dual blood-thinning therapy (two medicines) is as safe and effective as the standard longer period after a drug-coated balloon procedure for blocked heart arteries. You may join if you've already had the procedure and have been stable for a month.

NCT07592507Not yet recruiting· Phase 4
Blood thinner duration after balloon angioplasty for small heart arteries

This study compares taking blood-thinning medicine for 1 month versus 6 months after a balloon angioplasty to open a small heart artery. The goal is to find out which duration is safer and more effective for preventing future heart problems.

Hear when a new Percutaneous Coronary Intervention trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.